Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth

Becton, Dickinson and Company reported strong fourth-quarter sales, exceeding expectations. The company is focusing on higher-growth areas and innovation to enhance patient care. BD projects growth and increased dividends for FY25 despite challenges in China and the Pharma market.